MedPage Today on MSN
FDA approves at-home device for treatment-resistant depression
The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker ...
About 20% of U.S. adults experience major depression in their lifetime. For most people, symptoms improve within a few ...
Matthews, NC, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Southern Pain and Spine Specialists is proud to announce that Dr. Ammar ...
Valencia’s eCoin implantable tibial nerve stimulation (ITNS) system for urge urinary incontinence (UUI) treatment gained FDA ...
Archana Puran Singh has been diagnosed with a rare medical condition called complex regional pain syndrome. To know how it ...
Morning Overview on MSN
New discovery could prevent chemo nerve pain that won’t quit
Chemotherapy has long forced patients to choose between fighting their cancer and living with nerve pain that can linger for ...
Auricular vagal neuromodulation therapy is a non-invasive and non-surgical treatment that could aid cardiovascular disease ...
Chennai: In a first for Chennai, VS Hospitals has introduced Transcranial Magnetic Stimulation (TMS) therapy for the ...
Boston Scientific Corporation is rated a Hold with double-digit revenue growth and margin expansion. Learn more about BSX stock here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback